Ethical Implications of Nutrition Therapy at the End of Life
- PMID: 36862286
- DOI: 10.1007/s11894-023-00862-z
Ethical Implications of Nutrition Therapy at the End of Life
Abstract
Purpose of review: Provide an evidence-based resource to inform ethically sound recommendations regarding end of life nutrition therapy.
Recent findings: • Some patients with a reasonable performance status can temporarily benefit from medically administered nutrition and hydration(MANH) at the end of life. • MANH is contraindicated in advanced dementia. • MANH eventually becomes nonbeneficial or harmful in terms of survival, function, and comfort for all patients at end of life. • Shared decision-making is a practice based on relational autonomy, and the ethical gold standard in end of life decisions. A treatment should be offered if there is expectation of benefit, but clinicians are not obligated to offer non-beneficial treatments. A decision to proceed or not should be based on the patient's values and preferences, a discussion of all potential outcomes, prognosis for given outcomes taking into consideration disease trajectory and functional status, and physician guidance provided in the form of a recommendation.
Keywords: Artificial nutrition; End of life; Enteral nutrition; Ethics; Medically administered nutrition; Parenteral nutrition; Shared decision-making.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Konsman JP, Parnet P, Dantzer R. Cytokine. Trends Neurosci. 2002;25(3):154–9. https://doi.org/10.1016/s0166-2236(00)02088-9 . - DOI - PubMed
-
- Francesconi W, Sánchez-Alavez M, Berton F, Alboni S, Benatti C, Mori S, et al. The Proinflammatory Cytokine Interleukin 18 Regulates Feeding by Acting on the Bed Nucleus of the Stria Terminalis. J Neurosci. 2016;36(18):5170–80. https://doi.org/10.1523/jneurosci.3919-15.2016 . - DOI - PubMed - PMC
-
- Alboni S, Cervia D, Ross B, Montanari C, Gonzalez AS, Sanchez-Alavez M, et al. Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain. J Neuroimmunol. 2009;214(1–2):43–54. https://doi.org/10.1016/j.jneuroim.2009.06.016 . - DOI - PubMed - PMC
-
- Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7(1):9. https://doi.org/10.1186/1742-2094-7-9 . - DOI - PubMed - PMC
-
- Alboni S, Montanari C, Benatti C, Blom JMC, Simone ML, Brunello N, et al. Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain. Brain Behav Immun. 2011;25(3):483–93. https://doi.org/10.1016/j.bbi.2010.11.011 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials